Page 7 - Read Online
P. 7
Cancer Drug Resistance
CONTENTS
Topic: Advances in DNA Damage & Repair and Cancer Drug Resistance
1 Targeting DNA repair pathways to overcome cancer drug resistance
Robert C.A.M. van Waardenburg, Eddy S. Yang
Cancer Drug Resist 2021;4:837-841 https://dx.doi.org/10.20517/cdr.2021.80
2 Radiotherapy and the cellular DNA damage response: current and future perspectives on head
and neck cancer treatment
Maria Rita Fabbrizi, Jason L. Parsons
Cancer Drug Resist 2020;3:775-790 http://dx.doi.org/10.20517/cdr.2020.49
3 EGFR signaling promotes resistance to CHK1 inhibitor prexasertib in triple negative breast
cancer
Kevin J. Lee, Griffin Wright, Hannah Bryant, Leigh Ann Wiggins, Michele Schuler, Natalie R.
Gassman
Cancer Drug Resist 2020;3:980-991 http://dx.doi.org/10.20517/cdr.2020.73
4 Aberrant DNA repair as a potential contributor for the clonal evolution in subsets of anaplastic
thyroid carcinomas arising through dedifferentiation: implications for future therapeutic
algorithms?
Carl Christofer Juhlin
Cancer Drug Resist 2020;3:992-1000 http://dx.doi.org/10.20517/cdr.2020.66
5 Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia
Antoine N. Saliba, August J. John, Scott H. Kaufmann
Cancer Drug Resist 2021;4:125-142 http://dx.doi.org/10.20517/cdr.2020.95
6 Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal
tissue protection in radiotherapy
Jac A. Nickoloff, Lynn Taylor, Neelam Sharma, Takamitsu A. Kato
Cancer Drug Resist 2021;4:244-263 http://dx.doi.org/10.20517/cdr.2020.89
7 DNA direct reversal repair and alkylating agent drug resistance
Roberto Gutierrez, Timothy R. O’Connor
Cancer Drug Resist 2021;4:414-423 http://dx.doi.org/10.20517/cdr.2020.113
